U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock
73.47 USD
-0.05 (-0.07%)
73.47 USD
0 (0%)
USPH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of USPH get a neutral evaluation. Nothing too spectacular is happening here. USPH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year USPH was profitable.
In the past year USPH had a positive cash flow from operations.
In the past 5 years USPH has always been profitable.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 3.01%, USPH is doing good in the industry, outperforming 65.35% of the companies in the same industry.
USPH's Return On Equity of 7.15% is fine compared to the rest of the industry. USPH outperforms 68.32% of its industry peers.
USPH's Return On Invested Capital of 6.11% is fine compared to the rest of the industry. USPH outperforms 63.37% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for USPH is below the industry average of 9.22%.
The 3 year average ROIC (5.78%) for USPH is below the current ROIC(6.11%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROIC | 6.11% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH has a Profit Margin of 4.75%. This is in the better half of the industry: USPH outperforms 78.22% of its industry peers.
In the last couple of years the Profit Margin of USPH has declined.
Looking at the Operating Margin, with a value of 11.52%, USPH belongs to the top of the industry, outperforming 80.20% of the companies in the same industry.
In the last couple of years the Operating Margin of USPH has declined.
With a Gross Margin value of 18.80%, USPH is not doing good in the industry: 63.37% of the companies in the same industry are doing better.
USPH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
USPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for USPH has been increased compared to 1 year ago.
The number of shares outstanding for USPH has been increased compared to 5 years ago.
The debt/assets ratio for USPH has been reduced compared to a year ago.
2.2 Solvency
USPH has an Altman-Z score of 2.14. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score (2.14) which is in line with its industry peers.
USPH has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as USPH would need 2.82 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.82, USPH is in the better half of the industry, outperforming 77.23% of the companies in the same industry.
USPH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
USPH's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. USPH outperforms 67.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 2.14 |
ROIC/WACC0.72
WACC8.54%
2.3 Liquidity
USPH has a Current Ratio of 1.20. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH has a Current ratio (1.20) which is in line with its industry peers.
USPH has a Quick Ratio of 1.20. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH has a Quick ratio (1.20) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
USPH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.17%.
Measured over the past years, USPH shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.76% on average per year.
Looking at the last year, USPH shows a quite strong growth in Revenue. The Revenue has grown by 17.50% in the last year.
Measured over the past years, USPH shows a small growth in Revenue. The Revenue has been growing by 6.85% on average per year.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
3.2 Future
Based on estimates for the next years, USPH will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.98% on average per year.
Based on estimates for the next years, USPH will show a quite strong growth in Revenue. The Revenue will grow by 9.97% on average per year.
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 28.26 indicates a quite expensive valuation of USPH.
USPH's Price/Earnings is on the same level as the industry average.
USPH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 23.55, USPH is valued on the expensive side.
USPH's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of USPH to the average of the S&P500 Index (36.22), we can say USPH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.26 | ||
| Fwd PE | 23.55 |
4.2 Price Multiples
USPH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. USPH is cheaper than 68.32% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 66.34% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.63 | ||
| EV/EBITDA | 11.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USPH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of USPH may justify a higher PE ratio.
PEG (NY)3.01
PEG (5Y)N/A
EPS Next 2Y9.96%
EPS Next 3Y9.98%
5. Dividend
5.1 Amount
USPH has a Yearly Dividend Yield of 2.43%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.47, USPH pays a better dividend. On top of this USPH pays more dividend than 94.06% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.43% |
5.2 History
On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
75.41% of the earnings are spent on dividend by USPH. This is not a sustainable payout ratio.
USPH's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP75.41%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
73.47
-0.05 (-0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.82%
Inst Owner Change5.17%
Ins Owners1.84%
Ins Owner Change-1.14%
Market Cap1.12B
Revenue(TTM)758.71M
Net Income(TTM)36.02M
Analysts84.62
Price Target108.32 (47.43%)
Short Float %5.73%
Short Ratio4.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.43% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP75.41%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.82%
Min EPS beat(2)-3.42%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.36%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.56%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)2.04%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.02%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.88%
EPS NQ rev (3m)-3.88%
EPS NY rev (1m)0%
EPS NY rev (3m)5.2%
Revenue NQ rev (1m)1.41%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.26 | ||
| Fwd PE | 23.55 | ||
| P/S | 1.47 | ||
| P/FCF | 19.63 | ||
| P/OCF | 16.06 | ||
| P/B | 2.22 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.25 |
EPS(TTM)2.6
EY3.54%
EPS(NY)3.12
Fwd EY4.25%
FCF(TTM)3.74
FCFY5.1%
OCF(TTM)4.57
OCFY6.23%
SpS49.92
BVpS33.13
TBVpS-23.9
PEG (NY)3.01
PEG (5Y)N/A
Graham Number44.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROCE | 8.08% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.29% | ||
| ROICexgc | 36.03% | ||
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% | ||
| FCFM | 7.5% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 1.37 | ||
| Cap/Depr | 53.9% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | 9.84 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 157.98% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 2.14 |
F-Score6
WACC8.54%
ROIC/WACC0.72
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.12%
EBIT Next 3Y18.72%
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-4.01%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%
U.S. PHYSICAL THERAPY INC / USPH FAQ
What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?
ChartMill assigns a fundamental rating of 5 / 10 to USPH.
Can you provide the valuation status for U.S. PHYSICAL THERAPY INC?
ChartMill assigns a valuation rating of 4 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Fairly Valued.
What is the profitability of USPH stock?
U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for USPH stock?
The Earnings per Share (EPS) of U.S. PHYSICAL THERAPY INC (USPH) is expected to grow by 9.38% in the next year.
Can you provide the dividend sustainability for USPH stock?
The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 75.41%.